__timestamp | Alnylam Pharmaceuticals, Inc. | Merck & Co., Inc. |
---|---|---|
Wednesday, January 1, 2014 | 50561000 | 25469000000 |
Thursday, January 1, 2015 | 41097000 | 24564000000 |
Friday, January 1, 2016 | 47159000 | 25916000000 |
Sunday, January 1, 2017 | 76545000 | 27347000000 |
Monday, January 1, 2018 | 73106000 | 28785000000 |
Tuesday, January 1, 2019 | 194688000 | 32728000000 |
Wednesday, January 1, 2020 | 414801000 | 27900000000 |
Friday, January 1, 2021 | 704143000 | 35078000000 |
Saturday, January 1, 2022 | 868601000 | 41872000000 |
Sunday, January 1, 2023 | 1517886000 | 43989000000 |
Monday, January 1, 2024 | 1924873000 |
Unlocking the unknown
In the ever-evolving landscape of pharmaceuticals, the financial performance of companies can offer a glimpse into their strategic prowess. Over the past decade, Merck & Co., Inc. has consistently demonstrated its dominance, with gross profits soaring by approximately 72% from 2014 to 2023. In contrast, Alnylam Pharmaceuticals, Inc., a rising star in the biotech sector, has seen its gross profits increase by an impressive 2,900% during the same period, albeit from a much smaller base.
This financial narrative underscores the dynamic nature of the pharmaceutical industry, where established giants and innovative newcomers coexist, each shaping the future of healthcare in their unique ways.
Who Generates Higher Gross Profit? AbbVie Inc. or Alnylam Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Merck & Co., Inc. and Sanofi
Gross Profit Trends Compared: Merck & Co., Inc. vs Teva Pharmaceutical Industries Limited
Merck & Co., Inc. vs BioMarin Pharmaceutical Inc.: A Gross Profit Performance Breakdown
Merck & Co., Inc. vs Grifols, S.A.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Merck & Co., Inc. vs Alkermes plc
Merck & Co., Inc. and Travere Therapeutics, Inc.: A Detailed Gross Profit Analysis
Sanofi vs Alnylam Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gilead Sciences, Inc. and Alnylam Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Alnylam Pharmaceuticals, Inc. and Biogen Inc.: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs Viatris Inc.
Alnylam Pharmaceuticals, Inc. and Evotec SE: A Detailed Gross Profit Analysis